77 / 89
77
8.
Harding SJ, Mead GP, Bradwell AR, Berard AM. Serum
free light chain immunoassay as an adjunct to serum
protein
electrophoresis
and
immunofixation
electrophoresis in the detection of multiple myeloma and
other B-cell malignancies. Clin Chem Lab Med.
2009;47:302-4.
9.
Katzmann JA, Dispenzieri A, Kyle RA, Snyder MR,
Plevak MF, Larson DR, et al. Elimination of the need for
urine studies in the screening algorithm for monoclonal
gammopathies by using serum immunofixation and free
light chain assays. Mayo Clin Proc 2006;81:1575-8.
10.
Nair B, Waheed S, Szymonifka J, Shaughnessy JD Jr,
Crowley J, Barlogie B. Immunoglobulin isotypes in
multiple myeloma: laboratory correlates and prognostic
implications in total therapy protocols. Br J Haematol
2009;145:134-7.
11.
Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie
B, Bladé J, et al. International staging system for multiple
myeloma. J Clin Oncol. 2005;23:3412-20.
12.
Schmidt-Wolf IG, Glasmacher A, Hahn-Ast C, Jüttner A,
Schnurr T, Cremer F, et al. Chromosomal aberrations in
130 patients with multiple myeloma studied by
interphase FISH: diagnostic and prognostic relevance.
Cancer Genet Cytogenet 2006;167:20-5.
13.
Kumar S, Zhang L, Dispenzieri A, Van Wier S, Katzmann
JA, Snyder M, et al. Relationship between elevated
immunoglobulin free light chain and the presence of IgH
translocations in multiple myeloma. Leukemia.
2010;24(8):1498-505.
14.
Chang H, Sloan S, Li D, Zhuang L, Yi QL, Chen CI, et al.
The t(4;14) is associated with poor prognosis in myeloma
patients undergoing autologous stem cell transplant. Br J
Haematol 2004;125:64-8.